Pfizer Licenses Starna Therapeutics' CAR-T Programs for Autoimmune Diseases, Excluding Greater China
Trendline

Pfizer Licenses Starna Therapeutics' CAR-T Programs for Autoimmune Diseases, Excluding Greater China

What's Happening? Pfizer Inc. has entered into an exclusive licensing agreement with Starna Therapeutics, a biotechnology company specializing in RNA medicines. Under this agreement, Pfizer gains exclusive rights outside Greater China to develop, manufacture, and commercialize three pre-IND (Investi
AI Generated
This may include content generated using AI tools. Glance teams are making active and commercially reasonable efforts to moderate all AI generated content. Glance moderation processes are improving however our processes are carried out on a best-effort basis and may not be exhaustive in nature. Glance encourage our users to consume the content judiciously and rely on their own research for accuracy of facts. Glance maintains that all AI generated content here is for entertainment purposes only.